BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16543712)

  • 21. Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with chronic renal failure on hemodialysis treatment.
    Konno O; Hirano T; Katsuyama K; Oka K; Matsuno N; Nagao T
    Transpl Immunol; 2007 Apr; 17(3):187-92. PubMed ID: 17331845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a connection between inflammation, telomerase activity and the transcriptional status of telomerase reverse transcriptase in renal failure?
    Kordinas V; Tsirpanlis G; Nicolaou C; Zoga M; Ioannidis A; Ioannidou V; Bersimis S; Petrihou C; Savva L; Legakis NJ; Chatzipanagiotou S
    Cell Mol Biol Lett; 2015 Jun; 20(2):222-36. PubMed ID: 26204404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters.
    Bodlaj G; Berg J; Pichler R; Sailer T; Biesenbach G
    J Nephrol; 2004; 17(1):112-7. PubMed ID: 15151267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
    Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
    Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine production by mononuclear cells from patients with chronic renal failure.
    Weinstein T; Fishman P; Djaldetti M; Levi J
    Isr J Med Sci; 1993 Apr; 29(4):183-6. PubMed ID: 8491567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
    Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
    Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
    Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
    Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of anti-HCV positivity on markers of malnutrition and inflammation in hemodialysis patients.
    Zumrutdal A; Ozer B; Singan M; Micozkadioglu H; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2007; 29(1):85-90. PubMed ID: 17365915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study.
    Vaslaki LR; Berta K; Major L; Weber V; Weber C; Wojke R; Passlick-Deetjen J; Falkenhagen D
    Artif Organs; 2005 May; 29(5):406-12. PubMed ID: 15854217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation].
    Liang M; Wang L; Hou FF; Liu J; Liu ZQ; Tian JW
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased CD3+CD16+ natural killer-like T-cell percentage and zeta-chain expression accompany chronic inflammation in haemodialysis patients.
    Eleftheriadis T; Kartsios C; Yiannaki E; Antoniadi G; Kazila P; Pliakos K; Liakopoulos V; Markala D
    Nephrology (Carlton); 2009 Aug; 14(5):471-5. PubMed ID: 19486472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte telomere dynamics and telomerase activity in inflammatory bowel disease: effect of drugs and smoking.
    Getliffe KM; Al Dulaimi D; Martin-Ruiz C; Holder RL; von Zglinicki T; Morris A; Nwokolo CU
    Aliment Pharmacol Ther; 2005 Jan; 21(2):121-31. PubMed ID: 15679761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemodialysis induces mitochondrial dysfunction and apoptosis.
    Raj DS; Boivin MA; Dominic EA; Boyd A; Roy PK; Rihani T; Tzamaloukas AH; Shah VO; Moseley P
    Eur J Clin Invest; 2007 Dec; 37(12):971-7. PubMed ID: 18036031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomere shortening and haemodialysis.
    Boxall MC; Goodship TH; Brown AL; Ward MC; von Zglinicki T
    Blood Purif; 2006; 24(2):185-9. PubMed ID: 16373996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease.
    Sela S; Shurtz-Swirski R; Cohen-Mazor M; Mazor R; Chezar J; Shapiro G; Hassan K; Shkolnik G; Geron R; Kristal B
    J Am Soc Nephrol; 2005 Aug; 16(8):2431-8. PubMed ID: 15987755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PCR and in situ hybridization studies of telomerase subunits in human non-neoplastic livers.
    Harada K; Yasoshima M; Ozaki S; Sanzen T; Nakanuma Y
    J Pathol; 2001 Feb; 193(2):210-7. PubMed ID: 11180168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients.
    Kimmel M; Alscher DM; Dunst R; Braun N; Machleidt C; Kiefer T; Stülten C; van der Kuip H; Pauli-Magnus C; Raub U; Kuhlmann U; Mettang T
    Nephrol Dial Transplant; 2006 Mar; 21(3):749-55. PubMed ID: 16249205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodialysis related interleukin-2 receptor release by peripheral blood mononuclear cells.
    Memoli B; Libetta C; De Nicola L; Rampino T; Capuano A; Guida B; Andreucci VE
    ASAIO J; 1996; 42(1):60-3. PubMed ID: 8808460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
    Invernizzi P; Bernuzzi F; Lleo A; Pozzoli V; Bignotto M; Zermiani P; Crosignani A; Battezzati PM; Zuin M; Podda M; Raggi C
    Dig Liver Dis; 2014 Apr; 46(4):363-8. PubMed ID: 24378524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased SOCS expression in peripheral blood mononuclear cells of end stage renal disease patients is related to inflammation and dialysis modality.
    Rastmanesh MM; Braam B; Joles JA; Boer P; Bluyssen HA
    Eur J Pharmacol; 2009 Jan; 602(1):163-7. PubMed ID: 19041303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.